Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

J&J hands over compassionate use reviews to academics

May 7, 2015 Sales and Marketing J&J, JJ, academics, compac, eap, johnson

Johnson & Johnson has struck a ‘first-of-its-kind partnership’ with academic researchers to review requests for compassionate use of its investigational …
News

Alexion makes $8.4 billion Synageva purchase

May 7, 2015 Research and Development, Sales and Marketing Alexion, Shire, nps, rare disease, synageva

Rare disease specialist firm Alexion is splashing out $8.4 billion to buy fellow US orphan drug developer Synageva biopharmaceuticals. The …
News

Pfizer names new R&D leaders

May 7, 2015 Research and Development, Sales and Marketing John Lin, Michael Ehlers, Pfizer, rinat

Pfizer has confirmed two key appointments to lead its worldwide research and development organisation with immediate effect. The firm will …
News

Chiesi rapped for ABPI code breach

May 7, 2015 Medical Communications, Sales and Marketing ABPI, Chiesi, PMCPA

Chiesi made its sales reps go through a ‘tick-box’ compliance training exercise to get the pharma industry regulator ‘off its …
News

Celgene appoints European haematology and oncology head

May 7, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Celgene, Michael Zaiac

Swiss-based Celgene International Sàrl has appointed Michael Zaiac to the position of vice president of medical affairs for its European haematology …
Appointment

Generics continue to erode GSK sales

May 6, 2015 Sales and Marketing GSK, HIV, Novartis, Q1, ViiV, Witty, hampton, respiratory

GlaxoSmithKline’s pharma sales continued to slide in the first quarter of 2015, but ViiV healthcare and the portfolios acquired from …
News

ABPI appoints head of medical affairs from GSK

May 6, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Jacintha Sivarajah, acha

The ABPI has appointed Dr Jacintha Sivarajah as the body’s new head of medical affairs. Reporting directly to its executive …
Appointment

Lundbeck gains new chief executive from Novo Nordisk

May 6, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Kåre Schultz, Lundbeck, Novo Nordisk, Rebien Sorensen

Danish pharma giant Lundbeck has appointed Kåre Schultz as its new president and chief executive. Schultz (pictured) will take up …
Appointment

Teva forges ahead with Mylan pursuit

May 6, 2015 Sales and Marketing Mylan, Perrigo, Teva, generics

Teva has reinforced its commitment to buy Mylan despite previous rejection and only days after Mylan upped its own bid …
News

GSK files ultra-rare disease application with EMA

May 6, 2015 Research and Development, Sales and Marketing EMA, GSK, GSK2696273, Wiskott-Aldrich syndrome, bubble boy, metachromatic leukodystrophy

GlaxoSmithKline has become the first big pharma firm to file for a European marketing authorisation for a gene therapy to …
News

AbbVie’s Humira meets endpoint in eye disease study

May 6, 2015 Research and Development, Sales and Marketing AbbVie, FDA, Humira, Zydus Cadila, adalimumab, uveitis

In a Phase III trial AbbVie’s anti-inflammatory medicine Humira has been shown to significantly lower the risk of uncontrolled uveitis …
News

New chief business officer for Corium

May 6, 2015 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Joseph Sarret, corium

Dr Joseph Sarret has joined commercial-stage US biopharma firm Corium International in the newly-created position of chief business officer. 
Appointment

Chinese government to lift drug price controls

May 5, 2015 Sales and Marketing China, Drug pricing, GSK, IMS, Xarelto, government

The Chinese government has announced that it will remove price caps for most medicines and allow the market to play …
News

Bayer buys blood-thinning drug from Isis

May 5, 2015 Research and Development, Sales and Marketing Bayer, Eliquis, ISIS-FXI, Isis, Xarelto, blooding thinning

German drug giant Bayer is sealing a $155 million deal with Isis Pharmaceuticals to gain access to its anti-clotting treatment …
News

Worldwide cancer spending tops $100 billion

May 5, 2015 Research and Development, Sales and Marketing Cancer, IMS Health, keytruda, oncology

Over $100 billion was spent on cancer medicines across the world last year as a new generation of drugs begins …
News
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026